Initial experience with pulsed field ablation for atrial fibrillation

Area of Science:

• Electrophysiology
• Cardiovascular Medicine
• Medical Devices

Background:

• Symptomatic atrial fibrillation (AF) management often involves catheter ablation.
• Pulsed field ablation (PFA) is a novel technology designed for selective myocardial ablation.
• PFA aims to spare surrounding cardiac tissues during ablation procedures.

Purpose of the Study:

• To evaluate the initial clinical experience with a PFA catheter for pulmonary vein isolation (PVI).
• To describe procedural findings, safety, and learning curves associated with PFA in AF patients.
• To assess the efficacy of PFA in achieving pulmonary vein isolation.

Main Methods:

• A prospective study of 100 patients undergoing PFA for symptomatic AF between July 2021 and March 2022.
• Utilized the FARAWAVE PFA catheter system for pulmonary vein isolation procedures.
• Monitored procedural workflow, electrophysiological findings, complications, and operator learning curves.

Main Results:

• Pulmonary vein isolation was successfully achieved in all 100 patients (100%).
• The procedure demonstrated a short learning curve for operators, with no significant difference in procedure time between senior and junior operators.
• Only two minor complications (bleeding at access site) were reported, indicating a favorable safety profile.

Conclusions:

• PFA is a safe, rapid, and easily learnable technique for PVI in patients with atrial fibrillation.
• The initial experience suggests PFA is a promising alternative for AF ablation.
• Further studies are warranted to confirm long-term efficacy and safety.